Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRD1 | P41143 | 15/20 | 0.63 |
| ▸ | OPRM1 | P35372 | 9/20 | 0.63 |
| ▸ | OPRK1 | P41145 | 2/20 | 0.63 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29630599 | 0.94 | OPRD1 (0.63) | OPRD1OPRM1OPRK1 | |
| SCHEMBL11578512 | 0.90 | OPRD1 (0.66) | OPRD1OPRM1OPRK1 | |
| SCHEMBL9052245 | 0.90 | OPRD1 (0.70) | OPRD1OPRM1OPRK1 | |
| SCHEMBL29354962 | 0.90 | OPRD1 (0.70) | OPRD1OPRM1OPRK1 | |
| SCHEMBL29679587 | 0.89 | OPRD1 (0.59) | OPRD1OPRM1OPRK1 | |
| SCHEMBL30123118 | 0.89 | OPRD1 (0.56) | OPRD1OPRM1OPRK1 | |
| SCHEMBL29839256 | 0.89 | OPRD1 (0.56) | OPRD1OPRM1OPRK1 | |
| SCHEMBL29630566 | 0.88 | OPRD1 (0.55) | OPRD1OPRM1OPRK1 | |
| SCHEMBL30545070 | 0.88 | OPRD1 (0.72) | OPRD1OPRM1OPRK1 | |
| SCHEMBL29350666 | 0.88 | OPRD1 (0.72) | OPRD1OPRM1OPRK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240391951-A1 | NOVEL METHODS FOR PRODUCING PEPTIDE THIOESTER AND PEPTIDE | GLYTECH INC (JP) | 2024-11-28 | — | — | US | disclosed |
| US-12103947-B2 | Methods for producing peptide thioester and peptide | GLYTECH, INC. (JP) | 2024-10-01 | — | — | US | disclosed |
| US-20230143844-A1 | NOVEL METHODS FOR PRODUCING PEPTIDE THIOESTER AND PEPTIDE | GLYTECH, INC. (JP) | 2023-05-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230143844-A1 | NOVEL METHODS FOR PRODUCING PEPTIDE THIOESTER AND PEPTIDE | QPCT, PTMS, QPCTL | OPRD1 4547/4885OPRM1 4795/4885OPRK1 4579/4885 |
| US-12103947-B2 | Methods for producing peptide thioester and peptide | QPCT, QPCTL, PTMS | OPRD1 4532/4885OPRM1 4791/4885OPRK1 4536/4885 |
| US-20240391951-A1 | NOVEL METHODS FOR PRODUCING PEPTIDE THIOESTER AND PEPTIDE | QPCT, PTMS, QPCTL | OPRD1 4547/4885OPRM1 4795/4885OPRK1 4579/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.